Ticker Details
Equillium, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$120.76M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.84%
Avg Daily Range (30 D):	$0.10 | 5.06%
Avg Daily Range (90 D):	$0.08 | 5.13%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	297
Avg Trade Size (Sh.) (30 D):	156
Avg Trade Size (Sh.) (90 D):	204

Institutional Trades
Total Institutional Trades:	35
Avg Institutional Trade:	$1.18M
Avg Institutional Trade (30 D):	$.9M
Avg Institutional Trade (90 D):	$.9M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.49M
Avg Closing Trade (30 D):	$.65M
Avg Closing Trade (90 D):	$.65M
Avg Closing Volume:	203.32K

News

Mar 11, 2026 @ 6:00 AM Wereldhave, through Wereldhave Belgium, acquires s... Source: Na

Oct 22, 2025 @ 12:00 PM Equillium to Host Ulcerative Colitis KOL Event on ... Source: Equillium, Inc.

Sep 3, 2025 @ 11:30 AM These Were the 5 Top-Performing Stocks in the Nasd... Source: James Brumley

Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight

Sep 16, 2024 @ 1:00 PM Vivtex Enters New Research Agreement w... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.39	$.02	$-.39
Diluted EPS	$-.39	$.02	$-.39
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-22.4M	$-3.78M	$-22.4M
Operating Income / Loss	$-23.63M	$-3.96M	$-23.63M
Cost of Revenue
Net Cash Flow	$12.15M	$-2.88M	$12.15M
PE Ratio